Table 2. Cox proportional hazards model for ypN+ patients stratified by age.
HR | 95%CI | P | |
---|---|---|---|
Age < 73 years | |||
Histologic grade | |||
Well | 1.316 | 0.315–5.503 | 0.707 |
Moderate | 1 | ||
Poor/Undifferentiated | 2.395 | 1.336–4.295 | 0.003 |
Unknown | 0.565 | 0.134–2.383 | 0.437 |
Chemotherapy regimens | |||
5-FU | 1 | ||
Oxaliplatin | 0.449 | 0.225–0.899 | 0.024 |
Age ≥ 73 years | |||
ypN category | |||
ypN1a | 1 | ||
ypN1b | 0.951 | 0.444–2.036 | 0.898 |
ypN2a | 1.818 | 0.940–3.516 | 0.076 |
ypN2b | 3.217 | 1.484–6.974 | 0.003 |
Year of diagnosis | |||
1992–1996 | 39.044 | 4.084–373.260 | 0.001 |
1997–2000 | 2.237 | 0.944–5.304 | 0.068 |
2001–2004 | .920 | 0.451–1.878 | 0.820 |
2005–2008 | 1 | ||
HCC risk score | |||
1st quartile | 1 | ||
2nd quartile | 0.661 | 0.303–1.441 | 0.298 |
3rd quartile | 0.780 | 0.347–1.756 | 0.548 |
4th quartile | 2.361 | 1.206–4.624 | 0.012 |
Chemotherapy regimens | |||
5-FU | 1 | ||
Oxaliplatin | 1.484 | 0.701–3.142 | 0.303 |
Abbreviation: 5-FU, 5-fluorouracil; CI, Confidential intervals; HCC, Hierarchical Condition Categories.